Fauna Bio
Company
Fauna Bio develops one asset, preclinical (FAUN1083 in group 2 PH).
- 1
- Asset
- Furthest stage
- Preclinical
- Raised
- US$18m
- 0
- Trials
- 0
- Signals
Pipeline
1Preclinical, group 2 PH, HFpEF
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Funding rounds and grants2
- People18
- Similar companies1